Derek Maetzold

Derek Maetzold

Net worth: 5 M $ as of 31/05/2026

64 year
Health Technology
Commercial Services
Consumer Services

Profile

Derek J.
Maetzold
is the founder of Castle Biosciences, Inc., founded in 2007, where the title held is President, Chief Executive Officer & Director.
Current jobs include Director at AltheaDx, Inc. since 2021, Director at Prelude Corp.
since 2022, Director at Ocular Melanoma Foundation, and Director at IMPACT Melanoma, Inc. Former jobs include Director & Associate Director-Marketing at Amylin Pharmaceuticals, Inc. from 1996 to 1998, Senior Director-Business Development at Schering-Plough Corp.
from 1999 to 2003, Associate Director-Marketing at Sandoz Pharmaceuticals Corp.
from 1985 to 1996, Vice President-Sales & Marketing at Encysive Pharmaceuticals, Inc. from 2003 to 2008, and Account Supervisor at Integrated Communications Corp.
from 1998 to 1999.
Education includes undergraduate studies at George Mason University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/07/2026 250,239 ( 0.83% ) 5 M $ 31/05/2026

Derek Maetzold active positions

CompaniesPositionStart
CASTLE BIOSCIENCES, INC. Founder 01/09/2007
ALTHEADX INC Director/Board Member 26/05/2021
Director/Board Member -
Director/Board Member 02/02/2022

Former positions of Derek Maetzold

CompaniesPositionEnd
Sales & Marketing 01/05/2008
Corporate Officer/Principal 01/01/2003
Corporate Officer/Principal 01/01/1999
Director/Board Member 01/01/1998
Sandoz Pharmaceuticals Corp.
Sales & Marketing 01/01/1996
See the detail of Derek Maetzold's experience

Training of Derek Maetzold

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Sandoz Pharmaceuticals Corp.

Health Technology

Miscellaneous

  1. Stock Market
  2. Insiders
  3. Derek Maetzold